| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 15, 2014
MINNEAPOLIS - Jan. 15, 2014 - A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic (NYSE:MDT) CoreValve® System infringed on...
-
Jan 15, 2014
DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...
-
Jan 14, 2014Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Jan 13, 2014Brazil Acquisition, China Joint Venture Enable Company to Address Underserved Markets, Expand Patient Access to Care
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 13, 2014-- Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one...
-
Jan 9, 2014
MINNEAPOLIS - January 9, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet...
-
Jan 9, 2014New Therapeutic Device Company Launched by The Foundry
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 9, 2014-- Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a...
-
Jan 6, 2014
MINNEAPOLIS - Jan 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual J.P. Morgan Healthcare Conference on...
-
Jan 6, 2014
MINNEAPOLIS - Jan. 6, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of...
-
Jan 6, 2014
MINNEAPOLIS - Jan. 06, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug...
-
Dec 17, 2013
Thomson Reuters ONE via COMTEX) --Medtronic's Second Randomized, Controlled Renal Denervation Clinical Trial in the U.S. Will Potentially Expand Access to the Symplicity(TM) Renal Denervation...
-
Dec 9, 2013
Thomson Reuters ONE via COMTEX) --Medtronic Initiates Global Clinical Trial for Miniature Transcatheter Pacemaker System MINNEAPOLIS - December 9, 2013 - Continuing its leadership in advanced...
-
Dec 6, 2013
Thomson Reuters ONE via COMTEX) --Study Shows Prestige® Cervical Disc Replacement Maintained Clinical Improvements, Lower Rate of Additional Surgical Procedures Compared to ACDF MEMPHIS, TENN. -...
-
Dec 5, 2013
Thomson Reuters ONE via COMTEX) --Multi-Electrode System Built Upon Clinical Success and Strong Safety Profile of Single-Electrode Symplicity(TM) Renal Denervation System MINNEAPOLIS -- December...
-
Dec 5, 2013
(Thomson Reuters ONE via COMTEX) --Activa® PC+S Deep Brain Stimulation System Enables Research Toward Personalized Treatment of Neurological and Psychological Diseases MINNEAPOLIS - December 5,...
-
Dec 5, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - December 5, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the Company's common...
-
Dec 4, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Dec 4, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Oppenheimer...
-
Nov 26, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Nov 26, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Piper Jaffray...
-
Nov 25, 2013
Thomson Reuters ONE via COMTEX) --Presented at VEITH, Three-Year Clinical Data from Global ENGAGE Registry Supports Innovative Device's Market-Leading Position Worldwide MINNEAPOLIS -- Nov. 25,...
-
Nov 20, 2013
Thomson Reuters ONE via COMTEX) --Presented at VEITH, Acute Results from Initial Trial of New Medical Technology Show Promise for Endovascular Approach to Thoracic Aortic Aneurysms Involving Left...
-
Nov 19, 2013(Thomson Reuters ONE via COMTEX) --- Revenue of $4.2 Billion Grew 3.3% on a Constant Currency Basis; 2.4% as Reported
MINNEAPOLIS - Nov. 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2014, which ended October 25, 2013. The Company reported worldwide...
-
Nov 18, 2013
Thomson Reuters ONE via COMTEX) --MINERVA Trial at AHA Meeting Shows Medtronic Pacemakers Reduce the Progression of Permanent AF by 61 Percent MINNEAPOLIS and DALLAS - Nov.18, 2013 - New research...
-
Nov 15, 2013
Thomson Reuters ONE via COMTEX) --MINNEAPOLIS -- Nov. 15, 2013 -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the company's recently...
-
Nov 14, 2013
(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Nov. 14, 2013 - Medtronic, Inc. (NYSE: MDT) announced that a German court today ordered the discontinuation, in its entirety, of a prior court...
-
Nov 11, 2013
(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - Nov. 11, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2014 on...
-
Nov 7, 2013
Thomson Reuters ONE via COMTEX) --LIA Software Proven to Detect Lead Failures More Frequently Than Impedance Alone on Riata, Durata and Endotak Leads MINNEAPOLIS - Nov. 7, 2013 - Medtronic, Inc....